drugset / Trial / NCT00652821

Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions

NCT00652821 ↗

Phase 1 Completed 22 enrolled Par Pharmaceutical, Inc. AAI Clinic · collab
RandomizedCrossoverOpen-labelOther

Summary

To compare the relative bioavailability of Kali and Ortho-McNeil's products

Timeline

Start
2002-05
Primary completion
2002-08
Completion
2002-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Tramadol/APAP Unknown 37.5 mg —
Subject Tramadol/APAP Unknown 325 mg —

Indications

No indication recorded.